Title : The surgical management of early-stage cervical cancer
Abstract:
Background
Cervical cancer (CC) is an important cause of morbidity and mortality in women world- wide. Currently, radical hysterectomy (RH) with bilateral pelvic lymphadenectomy is the primary treatment for women with early stages (FIGO stages IA1 IB2 cervical cancer. Surgery is deemed to be the best option for young women with no comorbidities and when preservation of hormonal and sexual functions is relevant.
Methods
Systematic review of current literature on the surgical management of early-stage CC through PubMed focusing on English-language articles
Discussion
It is essential that tailored treatment that avoids morbidity while maintaining oncologic safety is offered to all women, which is already possible in high-income countries. We should Endeavour to make this a reality for low-income countries as well. In addition fertility preservation options in the management of CC should be offered to women.
Audience Take Away Notes:
- Options of management of early-stage cervical cancer
- Understand current evidence and how it applies to clinical practice
- Most recent evidence in the management of early stage cervical cancer
